This work was supported by a research grant from AMRAD Corporation Ltd, Richmond, Victoria, Australia. We thank K. Alitalo, University of Helsinki, for kindly providing the hVEGFR1/EpoR/pEF-BOS transfected BaF3 cell line used in the chimeric receptor cell-based assay.
| ||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |